SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10796	Companies
233363	Keywords
162043	Articles
124567	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 07/15/2025 at 18:30, 1 year ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 07/15/2025 at 18:30, 1 year ago

Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE

published on 06/30/2025 at 21:33, 1 year 1 month ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 06/30/2025 at 21:33, 1 year 1 month ago

Sanofi : Déclaration des transactions sur actions propres
BRIEF

published on 06/30/2025 at 07:35, 1 year 1 month ago

Sanofi Releases Q2 2025 Aide Mémoire

Forward-looking Statements Investor Information Financial Modeling Aide Mémoire Sanofi Q2 2025
BRIEF

published on 06/30/2025 at 07:35, 1 year 1 month ago

Sanofi publie son aide-mémoire pour le deuxième trimestre 2025

Informations Pour Les Investisseurs Énoncés Prospectifs Modélisation Financière Aide-mémoire Sanofi T2 2025
PRESS RELEASE

published on 06/30/2025 at 07:30, 1 year 1 month ago

Press release: Availability of the Q2 2025 Aide mémoire
Sanofi releases Q2 2025 Aide mémoire for financial modelling, to be published on July 31, 2025. Company details its commitment to innovation and impact in healthcare

Innovation Sanofi Aide Mémoire Financial Modelling Q2 2025
BRIEF

published on 06/25/2025 at 07:05, 1 year 1 month ago

Le riliprubart obtient le statut de médicament orphelin aux États-Unis

FDA Transplantation Rénale Médicament Orphelin Immunologie Riliprubart
BRIEF

published on 06/25/2025 at 07:05, 1 year 1 month ago

Riliprubart Granted Orphan Drug Designation in the United States

FDA Immunology Orphan Drug Riliprubart Kidney Transplant
PRESS RELEASE

published on 06/25/2025 at 07:00, 1 year 1 month ago

Communiqué de presse : Le riliprubart est désigné comme médicament orphelin aux États-Unis pour le rejet induit par les anticorps dans la transplantation d’organes solides
Sanofi obtient la désignation de médicament orphelin pour le riliprubart aux États-Unis, ciblant le rejet induit par les anticorps dans la transplantation d'organes solides

Sanofi Médicament Orphelin Riliprubart Transplantation D'organes Rejet Induit

Accesswire

Published on 08/03/2026 at 23:00, 4 hours 1 minute ago

Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:58, 3 days 1 hour ago

Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 3 days 1 hour ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days 1 hour ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days 2 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 23:33, 3 hours 27 minutes ago

EQS-Adhoc: Verbio SE: Preliminary EBITDA for FY 2025/2026 exceeds forecast
Published on 08/03/2026 at 23:20, 3 hours 41 minutes ago

DeFi Technologies Announces Shareholder Call to Discuss Q2 2026 Financial Results
Published on 08/03/2026 at 21:39, 5 hours 22 minutes ago

PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026
Published on 08/03/2026 at 19:35, 7 hours 26 minutes ago

Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
Published on 08/03/2026 at 19:01, 8 hours ago

EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026

Les Echos

Published on 08/03/2026 at 18:45, 8 hours 16 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 08/03/2026 at 18:45, 8 hours 16 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:35, 8 hours 26 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d'actions composant le capital social
Published on 08/03/2026 at 18:14, 8 hours 46 minutes ago

Évolution mensuelle du 31 juillet 2026
Published on 08/03/2026 at 18:00, 9 hours 1 minute ago

H1 2026 revenue

View all LES ECHOS COMFI WIRE